In the present study, SOCS1 and p21 were both identified as direct targets of miR-572 and could be suppressed by overexpression of miR-572, which in turn increased the proliferation and cell cycle progression of ovarian cancer cells in vitro and promoted tumorigenesis in an in vivo model of ovarian cancer. Here, CDKN1A is linked to ovarian carcinoma.